Innovation and Product Development news (page 5)

13 July 2026

GSK’s Jemperli shows sustained clinical complete responses in dMMR/MSI‑H locally advanced rectal cancer

Interim phase II results met primary endpoint (cCR12); trial suggests some patients may avoid chemo, radiation and surgery. Data to be shared with regulators including for US accelerated review.
13 July 2026

Takeda and Indonesia to build national plasma ecosystem for PDMPs

Fractionation license granted; $30M pilot to open plasma donation centers and assess local PDMP manufacturing, first donation center expected 2027.
11 July 2026

Novo Nordisk: denecimig (Mim8) shows positive long-term Phase 3 FRONTIER4 results in haemophilia A

Interim FRONTIER4 data show consistent safety and efficacy of denecimig across weekly, biweekly and monthly dosing, with low injection-site reactions and high zero-bleed rates.
10 July 2026

Merck: FDA approves KEYTRUDA and KEYTRUDA QLEX with Padcev for perioperative MIBC

FDA clears PD‑1 inhibitor plus antibody‑drug conjugate regimens with enfortumab vedotin as neoadjuvant and adjuvant therapy around cystectomy for adults with muscle‑invasive bladder cancer.
10 July 2026

Hansoh Pharma: Ris‑Rez (risvutatug rezetecan) ARTEMIS‑008 shows overall survival benefit in Chinese SCLC patients

Phase III trial met overall survival endpoint in advanced or relapsed small‑cell lung cancer in China, with consistent secondary benefits and no new safety signals.
10 July 2026

Nordic Ren-Gas and avanca/Alternoil sign €1bn renewable e‑methane offtake

Long-term €1bn offtake secures Tampere-produced e‑methane for heavy-duty transport via existing gas/LNG infrastructure across Europe.

The right choices in the European chemical industry

Save time with chemXplore Alpha

Learn more

← Previous Next →